CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income	$ 1,016	$ 13,457
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on impairments and disposal of assets	368	5,027
Amortization of intangibles	1,489	2,049
Depreciation	4,667	4,795
Non-cash compensation expense	7,789	11,274
Deferred income taxes	128	360
Bad debt expense	(129)	963
Amortization of debt issuance costs	612	1,959
Write-off of previously-capitalized debt issuance costs	0	2,373
Amortization of debt discount	6	0
Reduction in carrying amount of ROU asset, offset by change in operating lease liabilities	(1,007)	(877)
Gain on settlement of convertible debt	0	(34,308)
Changes in current assets and liabilities:
Accounts receivable	(8,235)	(211)
Prepaid and other current assets	(2,034)	(1,882)
Accounts payable, accrued expenses and other current liabilities	797	8,559
Income taxes receivable	86	42
Other, net	155	(424)
Net cash provided by operating activities	5,708	13,156
Cash flows from investing activities:
Capital expenditures	(2,746)	(2,452)
Net cash used in investing activities	(2,746)	(2,452)
Cash flows from financing activities:
Proceeds from term loan	125,000	0
Repayment of term loan	(625)	(625)
Payments related to net-share settlement of stock-based compensation, net of proceeds from exercise of stock options	(1,422)	(1,693)
Repurchase of 0.50% Convertible Senior Notes	0	(156,294)
Payment of debt issuance costs	(4,085)	(953)
Payment of original issue discount	(3,125)	0
Net cash provided by (used in) financing activities	115,743	(159,565)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents	118,705	(148,861)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period	112,056	298,969
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period	$ 230,761	$ 150,108